165 results
Page 4 of 9
8-K
EX-99.1
mavkyj3h
4 Oct 21
Neurobo Pharmaceuticals Announces $14 Million Registered Direct Offering
4:46pm
8-K
EX-10.1
1ew7hav69wgsgg dr
4 Oct 21
Neurobo Pharmaceuticals Announces $14 Million Registered Direct Offering
4:46pm
424B5
l17lqa2
4 Oct 21
Prospectus supplement for primary offering
4:31pm
8-K
EX-99.1
5msuvnwc
16 Aug 21
NeuroBo Pharmaceuticals Reports Second Quarter 2021 Financial Results
8:13am
8-K
EX-99.1
0yns7wdt
12 Jul 21
NeuroBo Pharmaceuticals’ Shareholders Elect Hyung Heon Kim and Andrew I. Koven to NeuroBo’s Board of Directors
8:41am
8-K
EX-99.1
50zqcg3 221
17 May 21
NeuroBo Pharmaceuticals Reports First Quarter 2021 Financial Results
5:03pm
424B3
1v5lmh
30 Apr 21
Prospectus supplement
5:13pm
8-K
EX-99.1
leyyhbxrod xie8kx
15 Apr 21
NeuroBo Pharmaceuticals Reports Full Year 2020 Financial Results and Provides Corporate Strategic Update
4:58pm
8-K
EX-99.1
ih8ntf0b5o
24 Mar 21
NeuroBo Pharmaceuticals Receives Approval for Amendment of Contingent Value Rights for Gemcabene
8:15am
8-K
EX-99.1
cp0gotz7u4uwz gg
5 Mar 21
Company Presentation Confidential March 2021
8:41am
424B3
pyr1ljf03d uutw8
1 Feb 21
Prospectus supplement
4:19pm
424B3
zwdlsud0vf te7
29 Jan 21
Prospectus supplement
9:20am